S.L.A. Pharma AG acquires pharmaceutical developments at an early stage from inventors (generally medical doctors). We then invest in patent and trademark protection, R&D and registration applications. Thereafter, S.L.A. Pharma AG seeks to license the marketing rights to larger pharmaceutical companies to carry out full-scale manufacturing and commercialisation. We have completed various licensing agreements with companies based in the USA, Japan and Europe.

S.L.A. Pharma AG has projects in phase III clinical trials, two orphan applications approved in Europe and the USA, and a further three projects in phase II.

For a full list of our current projects see our Therapeutic Areas.